Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality

Human serum albumin (HSA) is the frontline antioxidant protein in blood with established anti-inflammatory and anticoagulation functions. Here we report that COVID-19-induced oxidative stress inflicts structural damages to HSA and is linked with mortality outcome in critically ill patients. We recruited 25 patients who were followed up for a median of 12.5 days (1-35 days), among them 14 had died. Analyzing blood samples from patients and healthy individuals (n=10), we provide evidence that neutrophils are major sources of oxidative stress in blood and that hydrogen peroxide is highly accumulated in plasmas of non-survivors. We then analyzed electron paramagnetic resonance (EPR) spectra of spin labelled fatty acids (SLFA) bound with HSA in whole blood of control, survivor, and non-survivor subjects (n=10-11). Non-survivors HSA showed dramatically reduced protein packing order parameter, faster SLFA correlational rotational time, and greater S/W ratio (strong-binding/weak-binding sites within HSA), all reflecting remarkably fluid protein microenvironments. Stratified at the means, Kaplan-Meier survival analysis indicated that lower values of S/W ratio and accumulated H2O2 in plasma significantly predicted in-hospital mortality (S/W<0.16, 80% (9/12) vs. S/W>0.16, 20% (2/10), p=0.008; plasma [H2O2]>7.1 M, 83.3% (5/6) vs. 16.7% (1/6), p=0.049). When we combined these two parameters as the ratio ((S/W)/[H2O2]) to derive a risk score, the resultant risk score lower than the mean (< 0.0253) predicted mortality with 100% accuracy (100% (6/6) vs. 0% (0/6), logrank {chi}2 = 12.01, p = 5x10-4). The derived parameters may provide a surrogate marker to assess new candidates for COVID-19 treatments targeting HSA replacements.

[1]  C. Wiedermann Hypoalbuminemia as Surrogate and Culprit of Infections , 2021, International journal of molecular sciences.

[2]  E. Zaky,et al.  Autism spectrum disorder (ASD)-associated mitochondrial deficits are revealed in children’s platelets but unimproved by hyperbaric oxygen therapy , 2021, Free radical research.

[3]  R. Ohgami,et al.  A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity , 2020, International journal of laboratory hematology.

[4]  M. Hémadi,et al.  Tissue damage from neutrophil-induced oxidative stress in COVID-19 , 2020, Nature Reviews Immunology.

[5]  F. Cipollone,et al.  IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19 ? , 2020, Antioxidants & redox signaling.

[6]  J. Rotter,et al.  Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis , 2020, Journal of medical virology.

[7]  Jiaofeng Huang,et al.  Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity , 2020, Journal of medical virology.

[8]  T. Velavan,et al.  Mild versus severe COVID-19: Laboratory markers , 2020, International Journal of Infectious Diseases.

[9]  Guiqing He,et al.  Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China , 2020, Clinica Chimica Acta.

[10]  Jian-Ping Liu,et al.  The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients , 2020, International Immunopharmacology.

[11]  B. Nordestgaard,et al.  Plasma Albumin and Incident Cardiovascular Disease , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Gelos,et al.  Fatty Acid Binding to Human Serum Albumin in Blood Serum Characterized by EPR Spectroscopy , 2019, ChemistryOpen.

[13]  G. Corazza,et al.  Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis , 2019, Hepatology communications.

[14]  A. Meissner,et al.  T-Cell Accumulation in the Hypertensive Brain: A Role for Sphingosine-1-Phosphate-Mediated Chemotaxis , 2019, International journal of molecular sciences.

[15]  M. Ikura,et al.  Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis , 2018, Nature Communications.

[16]  A. Stewart,et al.  Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding , 2018, Prostaglandins, leukotrienes, and essential fatty acids.

[17]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[18]  S. Hallström,et al.  Anticoagulant action of low, physiologic, and high albumin levels in whole blood , 2017, PloS one.

[19]  N. Yamaotsu,et al.  Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin , 2017, PloS one.

[20]  S. Ali,et al.  Physiological and pathophysiological reactive oxygen species as probed by EPR spectroscopy: the underutilized research window on muscle ageing , 2016, The Journal of physiology.

[21]  Douglas G. Altman,et al.  Adequate sample size for developing prediction models is not simply related to events per variable , 2016, Journal of clinical epidemiology.

[22]  David G Levitt,et al.  Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements , 2016, International journal of general medicine.

[23]  P. Ascenzi,et al.  Heme-based catalytic properties of human serum albumin , 2015, Cell Death Discovery.

[24]  Philbert Lee,et al.  Review: modifications of human serum albumin and their binding effect. , 2015, Current pharmaceutical design.

[25]  M. Mojović,et al.  Binding of doxyl stearic spin labels to human serum albumin: an EPR study. , 2014, The journal of physical chemistry. B.

[26]  X. Salvatella,et al.  Human serum albumin, systemic inflammation, and cirrhosis. , 2014, Journal of hepatology.

[27]  W. Bal,et al.  Binding of transition metal ions to albumin: sites, affinities and rates. , 2013, Biochimica et biophysica acta.

[28]  T. Amisaki,et al.  Fatty acid binding to serum albumin: molecular simulation approaches. , 2013, Biochimica et biophysica acta.

[29]  U. Çakatay,et al.  Human serum albumin and its relation with oxidative stress. , 2013, Clinical laboratory.

[30]  Mehmet Kocak,et al.  A Simulation-Based Evaluation of the Asymptotic Power Formulas for Cox Models in Small Sample Cases , 2012, The American statistician.

[31]  V. Trezza,et al.  Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.

[32]  Thomas Agoritsas,et al.  Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure. , 2011, Journal of clinical epidemiology.

[33]  A. Miyanohara,et al.  Loss of Caveolin-1 Accelerates Neurodegeneration and Aging , 2010, PloS one.

[34]  H. Spiess,et al.  The distribution of fatty acids reveals the functional structure of human serum albumin. , 2010, Angewandte Chemie.

[35]  K. Schnurr,et al.  Fatty acid binding sites of human and bovine albumins: differences observed by spin probe ESR. , 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[36]  E. Bourdon,et al.  The antioxidant properties of serum albumin , 2008, FEBS letters.

[37]  S. Kazmierczak,et al.  Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. , 2006, Clinical chemistry.

[38]  S. Curry,et al.  Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. , 2006, Journal of molecular biology.

[39]  P. Ascenzi,et al.  Allosteric modulation of drug binding to human serum albumin. , 2006, Mini reviews in medicinal chemistry.

[40]  T. Robak,et al.  Interaction of doxorubicin and idarubicin with red blood cells from acute myeloid leukaemia patients , 2006, Cell biology international.

[41]  Enzo Terreno,et al.  The extraordinary ligand binding properties of human serum albumin , 2005, IUBMB life.

[42]  C. Curtain,et al.  Fatty-acid spin probe interactions with erythrocyte ghosts and liposomes prepared from erythrocyte ghosts , 1989, The Journal of Membrane Biology.

[43]  W. Vanderlaan,et al.  Effects of calcium, lanthanum, and temperature on the fluidity of spin-labeled human platelets , 2005, The Journal of Membrane Biology.

[44]  P. Sadler,et al.  Interdomain zinc site on human albumin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Hersmann,et al.  Albumin transport analysis of different collected and processed plasma products by electron spin resonance spectroscopy. , 2002, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[46]  H. Repo,et al.  Evaluation of red blood cell lysing solutions in the study of neutrophil oxidative burst by the DCFH assay. , 2001, Cytometry.

[47]  S. Curry,et al.  Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. , 2000, Journal of molecular biology.

[48]  P. Brick,et al.  Fatty acid binding to human serum albumin: new insights from crystallographic studies. , 1999, Biochimica et biophysica acta.

[49]  G. Zocchi,et al.  Osmotic pressure contribution of albumin to colloidal interactions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Powers,et al.  Iron-binding antioxidant potential of plasma albumin. , 1997, Clinical science.

[51]  B. Honoré,et al.  Influence of Fatty Acids on the Binding of Warfarin and Phenprocoumon to Human Serum Albumin with Relation to Anticoagulant Therapy , 1996, The Journal of pharmacy and pharmacology.

[52]  M. Cha,et al.  Glutathione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. , 1996, Biochemical and biophysical research communications.

[53]  ScienceDirect International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. , 1996 .

[54]  C. Cross,et al.  Oxidants, antioxidants, and respiratory tract lining fluids. , 1994, Environmental health perspectives.

[55]  J. Doweiko,et al.  Reviews: The Role of Albumin in Human Physiology and Pathophysiology, Part III: Albumin and Disease States , 1991 .

[56]  J P Doweiko,et al.  The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[57]  J. Freed,et al.  ESR studies of stearic acid binding to bovine serum albumin. , 1990, Biochimica et biophysica acta.

[58]  M. Shopova,et al.  Characterization of spin-labelled fatty acids and hematoporphyrin binding sites interactions in serum albumin. , 1990, Biochimica et biophysica acta.

[59]  B. Halliwell,et al.  Albumin--an important extracellular antioxidant? , 1988, Biochemical pharmacology.

[60]  C. Polnaszek,et al.  Spin labels in membranes. Problems in practice. , 1978, Biochimica et biophysica acta.

[61]  D. Eatough,et al.  The binding isotherms for the interaction of 5-doxyl stearic acid with bovine and human albumin. , 1978, Journal of lipid research.

[62]  A. Keith,et al.  Spin labels in membranes. , 1972, Chemistry and physics of lipids.

[63]  THE JOURNAL OF PHYSICAL CHEMISTRY B , 2022 .